Clinical Research Directory

Inclusion Criteria: 1. Age ≥18 female 2. Ability to read and write English 3. History of any stage of breast cancer 4. Completed primary treatment (chemotherapy, radiation and/or surgery) ≥3 months and ≤ 10 years prior to registration. Participants may use concurrent adjuvant endocrine therapy or HER2-targeted therapy while on study. 5. Able to engage in sexual activity including penetration or insertion into the vagina 6. Currently has a sexual partner. 7. Responds "yes" to "Do you currently experience vaginal or vulvar dryness and/or discomfort/pain with sexual activity?" 8. Responds "yes" to at least one of the following questions: * "Have you experienced negative changes in your body image since being diagnosed or treated for cancer?" or * "Have you experienced negative changes in your sexual desire since being diagnosed or treated for cancer?" Exclusion Criteria: 1. Antidepressants are allowed if a person has been on them for 30 days prior to registration, and dose or treatment is not expected to change. 2. An active psychiatric disorder that is or causing you symptoms or distress, such as major depressive disorder, bipolar disorder, obsessive compulsive disorder, PTSD, schizophrenia or borderline personality disorder (Defined per medical history and/or patient self-report) 3. Currently enrolled in another study that addresses sexual health (enrollment in other clinical trials will be allowed). 4. Previous participant in WISH Study 5. Currently receiving active treatment 6. Use of oral, transdermal or vaginal estrogen 7. Allergy or intolerance to Replens, Hyalo Gyn or any of their components.